Familial cholesterol tests from Gen-Probe, Progenika fall short of NICE expectations
This article was originally published in Clinica
Executive Summary
Two genetic tests that had promised a breakthrough in the screening and confirmatory diagnosis of familial hypercholesterolaemia (FH) do not demonstrate sufficient clinical- or cost-effectiveness for use in the UK’s NHS, according to provisional recommendations issued today by the National Institute for Health and Clinical Excellence (NICE).